Early research (Phase 1)Study completedNCT00339144What this trial is testingStudy of Dasatinib (BMS-354825) in Patients With Solid TumorsWho this might be right forTumors Bristol-Myers Squibb 16
Not applicableUnknownNCT06009835What this trial is testingDOTr/DOTa Algorithm Guidance for Refractory Solid TumorsWho this might be right forSolid TumorIndividuation Tianjin Medical University Second Hospital 15
Early research (Phase 1)Ended earlyNCT00358397What this trial is testingOne Time Injection of Bacteria to Treat Solid Tumors That Have Not Responded to Standard TherapyWho this might be right forTumors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT05605496What this trial is testingNP137 Clinical and Biological Activities Assessment in Patients With Advanced/Metastatic Solid Tumors Treated by Standard Anti PD-1/PD-L1 ImmunotherapiesWho this might be right forAdvanced Solid TumorsMetastatic Solid Tumors Centre Leon Berard 57
Early research (Phase 1)Study completedNCT02499224What this trial is testingSafety and Pharmacokinetics Study of YYB101 in Advanced Solid Tumors Patients Who Are Refractory to Standard TherapyWho this might be right forSolid Tumors CellabMED 39
Early research (Phase 1)Study completedNCT00509613What this trial is testingPhase 1 Study With Sorafenib and SirolimusWho this might be right forAdvanced Solid TumorRefractory to Standard Therapies Radboud University Medical Center
Testing effectiveness (Phase 2)Study completedNCT00598975What this trial is testingNKTR-102 in Combination With Cetuximab in Patients With Refractory Solid Tumors (Phase 2a) and Metastatic or Locally Advanced Colorectal Cancer (Phase 2b)Who this might be right forTumorColorectal Cancer Nektar Therapeutics 18
Testing effectiveness (Phase 2)Looking for participantsNCT06911333What this trial is testingAD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid TumorsWho this might be right forSolid Tumor, AdultTumor, SolidSolid Tumor+4 more Avelos Therapeutics Inc. 36
Early research (Phase 1)Study completedNCT00816400What this trial is testingA Dose Escalation, Dose Expansion Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-575, in Subjects With Advanced Tumors.Who this might be right forCancer MedImmune LLC 49
Early research (Phase 1)Study completedNCT00949949What this trial is testingEverolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard TherapyWho this might be right forCholangiocarcinoma of the GallbladderLocalized Gallbladder CancerUnresectable Gallbladder Cancer+1 more Mayo Clinic 38
Early research (Phase 1)Study completedNCT04676633What this trial is testingSafety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard TherapyWho this might be right forHepatocellular CarcinomaLiver MetastasesCholangiocarcinoma Sirnaomics 5
Early research (Phase 1)Ended earlyNCT01118819What this trial is testingSafety Study of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard TherapiesWho this might be right forSolid Tumor Malignancies BioMed Valley Discoveries, Inc 5
Early research (Phase 1)Study completedNCT00633269What this trial is testingStudy Assessing Metabolism, Excretion and Pharmacokinetics of a Poly (ADP-Ribose) Polymerase (PARP) Inhibitor in Patients With Solid Metastatic TumoursWho this might be right forNeoplasm Metastasis AstraZeneca 6
Testing effectiveness (Phase 2)Study completedNCT00284817What this trial is testingPhase I Study of MEDI522 in Patients With Irinotecan-Refractory Advanced Colorectal CancerWho this might be right forCancer MedImmune LLC 17
Early research (Phase 1)Study completedNCT00839631What this trial is testingDose Escalation Study of EC D-3263 HCl in Advanced Solid TumorsWho this might be right forSolid Tumors Dendreon 23
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06400160What this trial is testingClinical Trial of TB511 in Advanced Solid TumorsWho this might be right forNSCLCProstate CancerColorectal Cancer+1 more Twinpig Biolab, Inc. 12
Early research (Phase 1)Study completedNCT01346358What this trial is testingIMC-CS4 in Subjects With Advanced Solid TumorsWho this might be right forNeoplasms Eli Lilly and Company 52
Early research (Phase 1)Study completedNCT01014936What this trial is testingFirst-in-Man, Dose-escalation Trial of C-met Kinase Inhibitor MSC2156119J in Subjects With Advanced Solid TumorsWho this might be right forPatients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available EMD Serono 149
Early research (Phase 1)Study completedNCT01209143What this trial is testingPharmacokinetic Drug Interaction Study of the Hedgehog Pathway Inhibitor GDC-0449 in Combination With Rosiglitazone or Combined Oral Contraceptive in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy ExistsWho this might be right forSolid Cancers Genentech, Inc. 52
Early research (Phase 1)Study completedNCT00027898What this trial is testingBortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid TumorsWho this might be right forUnspecified Adult Solid Tumor, Protocol Specific National Cancer Institute (NCI) 27